相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL
J. R. Brown et al.
LEUKEMIA (2018)
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide
Koichi Takahashi et al.
BLOOD (2018)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
Lynne V. Abruzzo et al.
HAEMATOLOGICA (2018)
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
Lynne V. Abruzzo et al.
HAEMATOLOGICA (2018)
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption
Sofia Garces et al.
HUMAN PATHOLOGY (2018)
Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia
Shih-Han Lee et al.
NATURE (2018)
Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation
Valeria Buccheri et al.
ANNALS OF HEMATOLOGY (2018)
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia (vol 27, pg 2149, 2016)
M. Ladetto et al.
ANNALS OF ONCOLOGY (2018)
Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemia
Lili Wang et al.
GENOME RESEARCH (2017)
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia
M. Ladetto et al.
ANNALS OF ONCOLOGY (2016)
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Ferran Nadeu et al.
BLOOD (2016)
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia
Lili Wang et al.
CANCER CELL (2016)
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
Michael Hallek
LANCET ONCOLOGY (2016)
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau et al.
NATURE (2015)
Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations
John C. Riches et al.
BLOOD (2014)
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia
Jane Houldsworth et al.
LEUKEMIA & LYMPHOMA (2014)
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR Repository
Cecile Le Page et al.
BIOPRESERVATION AND BIOBANKING (2013)
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Zijun Y. Xu-Monette et al.
BLOOD (2012)
The B-cell receptor signaling pathway as a therapeutic target in CLL
Jennifer A. Woyach et al.
BLOOD (2012)
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays
M. Ciccone et al.
LEUKEMIA (2012)
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
Anna Yemelyanova et al.
MODERN PATHOLOGY (2011)
被撤回的出版物: Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (accelerated chronic lymphocytic leukemia) with aggressive clinical behavior (Retracted Article. See vol 95, pg 1620, 2010)
Eva Gine et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Thorsten Zenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Martin Koebel et al.
JOURNAL OF PATHOLOGY (2010)
Risk stratification in chronic lymphocytic leukemia
T Seiler et al.
SEMINARS IN ONCOLOGY (2006)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
